| human | Q5 |
| P496 | ORCID iD | 0000-0001-9249-9299 |
| P1153 | Scopus author ID | 11239744200 |
| P108 | employer | Medical University of Vienna | Q700731 |
| P735 | given name | Hedwig | Q19689438 |
| Hedwig | Q19689438 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q40341084 | Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24). |
| Q40294641 | Anticancer effects of zoledronic acid against human osteosarcoma cells. |
| Q24532945 | Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway |
| Q47144591 | Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas |
| Q39704810 | Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities |
| Q60596835 | Characterization of the Translation-dependent Step during Iron-regulated Decay of Transferrin Receptor mRNA |
| Q53208367 | Differential Effects of Variations at Codon 106 on Sprouty2 Functions in Lung Cancer-Derived Cells. |
| Q40131378 | Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms |
| Q39031611 | Expression of microRNA-21 in non-small cell lung cancer tissue increases with disease progression and is likely caused by growth conditional changes during malignant transformation |
| Q39725573 | Growth-regulated antisense transcription of the mouse thymidine kinase gene |
| Q37593267 | HO-1 inhibits preadipocyte proliferation and differentiation at the onset of obesity via ROS dependent activation of Akt2. |
| Q34427919 | Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. |
| Q38904547 | Hepatic Cholesterol-25-Hydroxylase Overexpression Improves Systemic Insulin Sensitivity in Mice |
| Q39160896 | In non-small cell lung cancer mitogenic signaling leaves Sprouty1 protein levels unaffected. |
| Q60596832 | MNS16A tandem repeat minisatellite of human telomerase gene and prostate cancer susceptibility |
| Q33709550 | MNS16A tandem repeat minisatellite of human telomerase gene: functional studies in colorectal, lung and prostate cancer. |
| Q28553450 | MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells |
| Q36021497 | Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). |
| Q39899665 | NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A. |
| Q42708398 | Overexpression of Aurora-A in primary cells interferes with S-phase entry by diminishing Cyclin D1 dependent activities |
| Q40975802 | Overexpression of the human antigen R suppresses the immediate paradoxical proliferation of melanoma cell subpopulations in response to suboptimal BRAF inhibition |
| Q24797215 | RNA-binding proteins to assess gene expression states of co-cultivated cells in response to tumor cells |
| Q53288639 | Response of experimental malignant melanoma models to the pan-Aurora kinase inhibitor VE-465. |
| Q92463760 | Spatial signal repression as an additional role of Sprouty2 protein variants |
| Q39129630 | Sprouty2 but not Sprouty4 is a potent inhibitor of cell proliferation and migration of osteosarcoma cells |
| Q92372490 | Sprouty3 and Sprouty4, Two Members of a Family Known to Inhibit FGF-Mediated Signaling, Exert Opposing Roles on Proliferation and Migration of Glioblastoma-Derived Cells |
| Q39036313 | Sprouty4 interferes with cell proliferation and migration of breast cancer-derived cell lines. |
| Q43060194 | Sprouty4 levels are increased under hypoxic conditions by enhanced mRNA stability and transcription |
| Q42137707 | Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells. |
| Q37849781 | Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy. |
| Q40957092 | The increased Sprouty4 expression in response to serum is transcriptionally controlled by Specific protein 1. |
| Q40328513 | The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals |
| Q41133806 | Thymidine inhibits the growth-arrest-specific degradation of thymidine kinase protein in transfected L fibroblasts |
Search more.